Latest Breaking News On - Inozyme pharma inc - Page 13 : comparemela.com

Inozyme Pharma, Inc Announces Closing of Public Offering of Common Stock

01.08.2023 - BOSTON, Aug. 01, 2023 (GLOBE NEWSWIRE) - Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today .

United statesNew yorkPiper sandlerWedbush pacgrowInozyme pharmaMatt peraStefan rileyExchange commissionProspectus departmentInozyme pharma incCorporate communicationsNeedham companyBofa securitiesTryon street

Inozyme Pharma, Inc Announces Proposed Offering of Common Stock

Inozyme Pharma, Inc Announces Proposed Offering of Common Stock
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesInozyme pharmaPiper sandlerMatt peraStefan rileyInozyme pharma incProspectus departmentCorporate communicationsExchange commissionBofa securitiesTryon streetPrivate securities litigation reform act

Inozyme Pharma, Inc Announces Pricing of Public Offering of Common Stock

BOSTON, July 27, 2023 Inozyme Pharma, Inc. , a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal.

United statesNew yorkWedbush pacgrowStefan rileyMatt peraPiper sandlerInozyme pharmaProspectus departmentNeedham companyGlobenewswire incCorporate communicationsExchange commissionInozyme pharma incTryon streetPrivate securities litigation reform act

Inozyme Pharma (INZY) Announces $60M Proposed Offering of Common Stock

Inozyme Pharma (INZY) Announces $60M Proposed Offering of Common Stock
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerInozyme pharma incInozyme pharma

Inozyme Pharma, Inc Announces Proposed Offering of Common

BOSTON, July 27, 2023 (GLOBE NEWSWIRE) Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel.

United statesNew yorkMatt peraStefan rileyInozyme pharmaPiper sandlerCorporate communicationsProspectus departmentExchange commissionInozyme pharma incBofa securitiesTryon streetPrivate securities litigation reform actNasdaq inzyNozyme pharma inc